{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:34:08Z","timestamp":1793370848595,"version":"4.5.0"},"reference-count":22,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Given the rising prevalence of psychiatric symptomatology among college students, this analysis aims to identify temporal trends in psychiatric medication usage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This analysis used data from the Healthy Minds Study Survey administered between 2007 and 2019, yielding a sample of 320,817 university students. Survey data were examined via descriptive analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Over the last decade from 2007 to 2018\u20132019, there was an increase in use of nearly all classes of psychiatric medications, with reported antidepressant medication (selective serotonin reuptake inhibitors [SSRIs], serotonin\u2010norepinephrine reuptake inhibitors [SNRIs], etc.) use increasing from 8.0% to 15.3%, anti\u2010anxiety medication (benzodiazepines, buspirone, etc.) from 3.0% to 7.6%, psychostimulants from 2.1% to 6.3%, antipsychotics from 0.38% to 0.92%, and mood stabilizers from 0.8% to 2.0% (all\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&lt;\u00a00.0001), respectively. In addition, the use of more than one category of medication at a time has increased, from 28.2% in 2007 to 40.8% in 2018\u20132019 (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&lt;\u00a00.0001). The proportion of students who received their most recent prescription for psychiatric medication from primary care providers has risen from 49.1% in 2007 to 58.8% in 2018\u20132019 (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&lt;\u00a00.0001), while the proportion receiving these prescriptions from psychiatric providers did not increase significantly and stands at 36.1% in 2018\u20132019. The percentage of students taking psychiatric medication without a prescription varied from year to year, starting at 11.9% in 2007 and ending at 7.7% in 2018\u20132019 (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&lt;\u00a00.0001). The proportion of students who discussed their use of psychiatric medication with their doctor or other health professional three or more times in the previous year has increased from 39.2% in 2007 to 49.5% in 2018\u20132019 (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&lt;\u00a00.0001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The proportion of college students who have taken psychiatric medications of all categories has risen in the last decade; these students are increasingly likely to be on more than one kind of psychiatric medication and be treated by healthcare providers at a greater frequency. Despite the growing complexity of student treatment, the proportion of students receiving psychiatric medication management by psychiatric providers has not changed, while the proportion receiving services in primary care settings has increased.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/phar.2513","type":"journal-article","created":{"date-parts":[[2021,2,14]],"date-time":"2021-02-14T11:29:07Z","timestamp":1613302147000},"page":"350-358","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Use of psychiatric medication by college students: A decade of data"],"prefix":"10.1002","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6187-3938","authenticated-orcid":false,"given":"Marcia R.","family":"Morris","sequence":"first","affiliation":[{"name":"Department of Psychiatry College of Medicine University of Florida Gainesville Florida USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin C.","family":"Hoeflich","sequence":"additional","affiliation":[{"name":"Department of Epidemiology College of Public Health and Health Professions University of Florida Gainesville Florida USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Nutley","sequence":"additional","affiliation":[{"name":"Department of Epidemiology College of Public Health and Health Professions University of Florida Gainesville Florida USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicki L.","family":"Ellingrod","sequence":"additional","affiliation":[{"name":"College of Pharmacy University of Michigan Ann Arbor Michigan USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle B.","family":"Riba","sequence":"additional","affiliation":[{"name":"Department of Psychiatry Michigan Medicine University of Michigan Ann Arbor Michigan USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine W.","family":"Striley","sequence":"additional","affiliation":[{"name":"Department of Epidemiology College of Public Health and Health Professions University of Florida Gainesville Florida USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,3,5]]},"reference":[{"key":"e_1_2_8_2_1","unstructured":"GallagherRP.National Survey of College Counseling Centers 2014. American College Counseling Association.http:\/\/d\u2010scholarship.pitt.edu\/28178\/1\/survey_2014.pdf. Accessed December 12 2020."},{"key":"e_1_2_8_3_1","unstructured":"Healthy Minds Study 2018\u20132019. Healthy Minds Network.https:\/\/healthymindsnetwork.org\/wp\u2010content\/uploads\/2019\/09\/HMS_national\u20102018\u201019.pdf. Accessed December 19 2020."},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201800332"},{"key":"e_1_2_8_5_1","volume-title":"Monitoring the Future National Survey Results on Drug Use, 1975\u20132009","author":"Johnston LD","year":"2010"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.3109\/00952990.2011.643992"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.13766"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/NMD.0b013e3182175123"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2012.01.002"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2012.02.008"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.17m11958"},{"key":"e_1_2_8_12_1","unstructured":"Benzodiazepines and Opioids. National Institute on Drug Abuse.https:\/\/www.drugabuse.gov\/drug\u2010topics\/opioids\/benzodiazepines\u2010opioids. Accessed August 25 2020."},{"key":"e_1_2_8_13_1","unstructured":"America\u2019s State of Mind: U.S. trends in medication use for depression anxiety and insomnia. An Express Scripts Report. 2020 April.https:\/\/www.express\u2010scripts.com\/corporate\/americas\u2010state\u2010of\u2010mind\u2010reporthttps:\/\/corporate\u2010site\u2010labs\u2010prod.s3.us\u2010east\u20102.amazonaws.com\/2020\u201004\/Express%20Scripts%20America%27s%20State%20of%20Mind%20Report%20April%202020%20FINAL_p9%20edits_0.pdf. Accessed August 25 2020."},{"key":"e_1_2_8_14_1","unstructured":"LowryF.Prescribing benzodiazepines as needed may promote misuse. Medscape Psychiatry. 2020 April 16.https:\/\/www.medscape.com\/viewarticle\/873168#vp_a. Accessed December 19 2020."},{"key":"e_1_2_8_15_1","unstructured":"Overdose Death Rates. National Institute of Drug Abuse.https:\/\/www.drugabuse.gov\/drug\u2010topics\/trends\u2010statistics\/overdose\u2010death\u2010rates. Accessed August 25 2020."},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2009.175"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.4103\/0973-1229.104497"},{"key":"e_1_2_8_18_1","unstructured":"FDA Requiring Labeling Changes for Benzodiazepines. U.S. Food and Drug Administration. 2020 September 23.https:\/\/www.fda.gov\/news\u2010events\/press\u2010announcements\/fda\u2010requiring\u2010labeling\u2010changes\u2010benzodiazepines. Accessed October 25 2020."},{"key":"e_1_2_8_19_1","unstructured":"GroholJ.PsychCentral. Top 25 Psychiatric Medications for 2018. 2019 December 15.https:\/\/psychcentral.com\/blog\/top\u201025\u2010psychiatric\u2010medications\u2010for\u20102018\/. Accessed August 25 2020."},{"key":"e_1_2_8_20_1","unstructured":"WeinerS.Addressing the escalating psychiatrist shortage. AAMC Health Care Work Force. 2018 February 12.https:\/\/www.aamc.org\/news\u2010insights\/addressing\u2010escalating\u2010psychiatrist\u2010shortage. Accessed December 13 2020."},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201900392"},{"key":"e_1_2_8_22_1","unstructured":"Prescription drug abuse common among college students including those at OU. Campus Drug Prevention. 2020 February 3.https:\/\/www.campusdrugprevention.gov\/news\/prescription\u2010drug\u2010abuse\u2010common\u2010among\u2010collegestudents\u2010including\u2010those\u2010ou. Accessed August 25 2020."},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2018.04.014"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/phar.2513","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/phar.2513","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/phar.2513","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:10:09Z","timestamp":1761048609000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1002\/phar.2513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,5]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1002\/phar.2513"],"URL":"https:\/\/doi.org\/10.1002\/phar.2513","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"value":"0277-0008","type":"print"},{"value":"1875-9114","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,5]]},"assertion":[{"value":"2020-11-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}